Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration-Time Curve of Linezolid for Different ABCB1 Genotypes.

Autor: Allegra S; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., Di Paolo A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Cusato J; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., Fatiguso G; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., Arrigoni E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Danesi R; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Corcione S; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy., DʼAvolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy.
Jazyk: angličtina
Zdroj: Therapeutic drug monitoring [Ther Drug Monit] 2019 Apr; Vol. 41 (2), pp. 254-255.
DOI: 10.1097/FTD.0000000000000596
Databáze: MEDLINE